Furthermore, silencing of SKP2 expression by siRNA resulted in increased levels of p27Kip1, strongly suggesting a potential role of bortezomib-mediated apoptosis in CML cell lines. This evidence concerns the gene SKP2 and chronic myelogenous leukemia, BCR-ABL1 positive.